Citation Impact

Citing Papers

Voltage sensor conformations in the open and closed states in rosetta structural models of K + channels
2006 StandoutNobel
A fluorescent probe designed for studying protein conformational change
2005 StandoutNobel
Mechanism of action of voltage‐gated K+ channel antibodies in acquired neuromyotonia
2004
Activation of Store-Operated Ca2+ Current in Xenopus Oocytes Requires SNAP-25 but Not a Diffusible Messenger
1999 StandoutNobel
Defective recycling of synaptic vesicles in synaptotagmin mutants of Caenorhabditis elegans
1995 StandoutNatureNobel
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
2001 Standout
Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice
2003
Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction
2005
Myasthenia Gravis
1988
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Myasthenia Gravis
2016 Standout
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
1991
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Tetanus toxin inhibits spontaneous quantal release and cleaves VAMP/synaptobrevin
1995
Nitric oxide signaling and the regulation of myocardial function
2008
The Lambert-Eaton Myasthenic Syndrome
2001
The Orientation and Molecular Movement of a K+ Channel Voltage-Sensing Domain
2003
Measurement of the movement of the S4 segment during the activation of a voltage-gated potassium channel
1996
Assignment of the human nicotinic acetylcholine receptor genes: the alpha and delta subunit genes to chromosome 2 and the beta subunit gene to chromosome 17
1990
X-ray structure of a voltage-dependent K+ channel
2003 StandoutNatureNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Voltage-Sensing Arginines in a Potassium Channel Permeate and Occlude Cation-Selective Pores
2005
Guillain-Barré syndrome
2016 Standout
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
1996 Standout
Autoantibody Specificities in Lambert‐Eaton Myasthenic Syndrome
1993
Botulinum Toxin as a Biological Weapon
2001 Standout
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
1991 Standout
Courtship and Visual Defects of cacophony Mutants Reveal Functional Complexity of a Calcium-Channel α1 Subunit in Drosophila
1998 StandoutNobel
Cancer immunotherapy via dendritic cells
2012 Standout
Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators
2008
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication
1993 StandoutNobel
A Bivalent Tarantula Toxin Activates the Capsaicin Receptor, TRPV1, by Targeting the Outer Pore Domain
2010 StandoutNobel
Quantal Neurotransmitter Release and the Clostridial Neurotoxins’ Targets
1995
Depolarization Induces Intersubunit Cross-linking in a S4 Cysteine Mutant of the Shaker Potassium Channel
2002
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
2004
Structural Basis of Inward Rectification
2002 StandoutNobel
Myasthenia Gravis
1994 Standout
Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals
1998
Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses
1990
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Immunotherapy in autoimmune neuromuscular disorders
2002
Characterization of the Inhibitory Action of Botulinum Neurotoxin Type A on the Release of Several Transmitters from Rat Cerebrocortical Synaptosomes
1988
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Autoimmune Disorders of Neuronal Potassium Channels
2003
Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens
2013
Changes in activation gating of IsK potassium currents brought about by mutations in the transmembrane sequence
1994
Paraneoplasia and Autoimmunologic Injury of the Nervous System: The Anti‐Hu Syndrome
1993
Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction
1989
From Ionic Currents to Molecular Mechanisms
2000 Standout
AAEE minimonograph #33: Electrodiagnostic approach to defects of neuromuscular transmission
1989
Antibody Heterogeneity and Specificity in Myasthenia Gravisa
1987
Structure and function of tetanus and botulinum neurotoxins
1995
KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells
2000
Constitutively active and G-protein coupled inward rectifier K+ channels: Kir2.0 and Kir3.0
2007
Lambert‐eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation
1988
Botulism
2000
Reconstructing Voltage Sensor–Pore Interaction from a Fluorescence Scan of a Voltage-Gated K+ Channel
2000
Molecular mechanism of voltage sensor movements in a potassium channel
2004
The principle of gating charge movement in a voltage-dependent K+ channel
2003 StandoutNatureNobel
Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes
2009
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
1996
Non-synaptic ion channels in insects — basic properties of currents and their modulation in neurons and skeletal muscles
2001
A Yeast Genetic Screen Reveals a Critical Role for the Pore Helix Domain in TRP Channel Gating
2008 StandoutNobel
Antibodies to Neuronal Targets in Neurological and Psychiatric Diseases
2003
Polymyositis and dermatomyositis
2003 Standout
Paraneoplastic syndromes of the spinal cord, nerve, and muscle
2000
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Immunological and pathological study of anti‐Ri–associated encephalopathy
1994
Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity
1991 StandoutNobel
Guillain-Barré syndrome
2005 Standout
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
Perisynaptic satellite cells in human external intercostal muscle: A quantitative and qualitative study
1989
Phosphorylation of synaptotagmin I by casein kinase II.
1993 StandoutNobel
Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis
2013
Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
1993
Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
1994 StandoutNobel
IgG from Patients with Lambert-Eaton Syndrome Blocks Voltage-Dependent Calcium Channels
1988 StandoutScienceNobel
The Three Es of Cancer Immunoediting
2004 Standout
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.
1996
Inactivation of a Serotonin-Gated Ion Channel by a Polypeptide Toxin from Marine Snails
1998 StandoutScienceNobel
Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
1988
How Does Voltage Open an Ion Channel?
2006
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Acetylcholine receptor kinetics
1981
Diversity of Conus Neuropeptides
1990 Science
Membrane Fusion and Exocytosis
1999 StandoutNobel
Molecular aspects of the trophic influence of nerve on muscle
1983
Patch Clamp Techniques for Studying Ionic Channels in Excitable Membranes
1984 StandoutNobel
Detection of Calcium Transients inDrosophilaMushroom Body Neurons with Camgaroo Reporters
2003 StandoutNobel
Evidence for synaptotagmin as an inhibitory clamp on synaptic vesicle release in Aplysia neurons.
1995 StandoutNobel
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome
2001
Protein Kinase G Phosphorylates Cav1.2 α1cand β2Subunits
2007
The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
1992
Specificity of Charge-carrying Residues in the Voltage Sensor of Potassium Channels
2004
Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses
1997 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
Assembly of SNARE Core Complexes Prior to Neurotransmitter Release Sets the Readily Releasable Pool of Synaptic Vesicles
2000 StandoutNobel
Substance P reduces acetylcholine‐induced currents in isolated bovine chromaffin cells.
1984 StandoutNobel
Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes
1990
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes
1987
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
1994 StandoutNobel
STRUCTURE AND FUNCTION OF NEUROMUSCULAR JUNCTIONS IN THE VASTUS LATERALIS OF MAN
1992
Neurotoxins Affecting Neuroexocytosis
2000 Standout
Multiple Domains of Botulinum Neurotoxin Contribute to Its Inhibition of Transmitter Release in Aplysia Neurons
1989
Molecular Models of Voltage Sensing
2002
Structural basis for gating charge movement in the voltage sensor of a sodium channel
2011 StandoutNobel

Works of D. Wray being referenced

Modulation by protein kinase A of a cloned rat brain potassium channel expressed in Xenopus oocytes
1994
Conserved extracellular cysteine residues in the inwardly rectifying potassium channel Kir2.3 are required for function but not expression in the membrane
1999
Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction
1993
THE SLOW CHANNEL SYNDROME
1987
Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Functiona
1993
Lambert‐Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones
1987
Effect of cysteine substitutions on the topology of the S4 segment of the Shaker potassium channel: implications for molecular models of gating
1999
Regulation of Cloned Cardiac L-type Calcium Channels by cGMP-dependent Protein Kinase
2000
Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
1986
Congenital myasthenia: Further evidence of disease heterogeneity
1986
Effect of the Calcium‐Channel Agonist CGP 28392 on Transmitter Release at Mouse Neuromuscular Junctions
1989
Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
1990
Prolonged exposure to acetylcholine: noise analysis and channel inactivation in cat tenuissimus muscle.
1981
Actions of β-bungarotoxin on spontaneous release of transmitter at muscle end-plates treated with botulinum toxin
1986
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.
1983
The effects of in vitro application of purified botulinum neurotoxin at mouse motor nerve terminals.
1987
Action of Lambert‐Eaton myasthenic syndrome IgG at mouse motor nerve terminals
1985
Frequency of opening of channels by depolarizing drugs [proceedings].
1978
The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
1987
Calcium Channel Currents In Neurones From Locust (Schistocerca Gregaria) Thoracic Ganglia
1993
Rankless by CCL
2026